This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02662/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02662/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02662/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02662/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02662/identifier/drugbank/

Statements

Subject Item
n2:DB02662
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02662 n10:DB02662
dcterms:title
Novo Nordisk a/S Compound
adms:identifier
n8:1763 n11:1829 n12:46505054 n13:DB02662 n14:878
n3:IUPAC-Name
n4:271B4C78-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4C7E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4C7D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4C7A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4C7B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4C7C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4C76-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4C77-363D-11E5-9242-09173F13E4C5 n4:271B4C74-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4C75-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4C84-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4C85-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4C7F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4C80-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4C82-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4C81-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4C83-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4C8A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C8C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C8D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C89-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C88-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C8B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4C79-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4C86-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C87-363D-11E5-9242-09173F13E4C5